Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...
(RTTNews) - Novo Nordisk (NVO) has expanded its $499 per month Wegovy savings program to include all cash-paying patients. Till now, the reduced price offer was only available with NovoCare pharmacy.
Until today, the $499-per-month offer for Wegovy ® was only available via the recently launched NovoCare ® Pharmacy. "At Novo Nordisk, we are committed to developing innovative medicines and ...
Novo Nordisk has updated its Wegovy savings program ... according to a March 24 news release from the company. The savings offer applies to all Wegovy dose strengths and replaces the previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results